Gycabiane and Glycemic Control of Prediabetic Subjects
- Conditions
- Hyperglycemia
- Interventions
- Dietary Supplement: GlycabianeDietary Supplement: placebo
- Registration Number
- NCT01530685
- Lead Sponsor
- PiLeJe
- Brief Summary
The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.
- Detailed Description
Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear.
The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 83
- Male or female from 25 to 65 years old
- 1.0g/L ≤ fast blood glucose < 1.26g/L
- overweight (IMC > 25)
- thyroid disease
- hypogonadism
- History of musculoskeletal, autoimmune or neurological disease
- Treatment against thyroid disease, hypoglycemia, hypertension, or anti-coagulant
- Pregnant or lactating women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Glycabiane, gelule Glycabiane - Placebo placebo -
- Primary Outcome Measures
Name Time Method Fast Blood Glucose 4 months Fast blood glucose will be measured before and after 4 months of supplementation and after 2 months of wash-out
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU Pitié Salpetriere
🇫🇷Paris, France